Evidence map›Paper›PMID 40097961›Full record

ArticlePilot and feasibility studies2025

A high-dose mobility booster program versus usual care for people after stroke: protocol for a pilot randomized trial.

Katharine Scrivener, Elisha Ball, Catherine Dean, Joanne Glinsky, Louise Ada, Petra Graham, Nicholas Young, Karen Felton, Natasha A Lannin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pilot and feasibility studies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katharine ScrivenerDepartment of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.
Elisha BallDepartment of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.
Catherine DeanDepartment of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.
Joanne GlinskyFaculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Louise AdaFaculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Petra GrahamDepartment of Mathematics and Statistics, Macquarie University, Sydney, Australia.
Nicholas YoungConcentric Healthcare Services, Sydney, Australia.
Karen FeltonDepartment of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.
Natasha A LanninBrain Recovery and Rehabilitation Group, Department of Neurosciences, Monash University, Allied Health, Alfred Health, 99 Commercial Road, Melbourne, Victoria, Australia. Natasha.Lannin@monash.edu.ORCID http://orcid.org/0000-0002-2066-8345

Funding

National Heart Foundation of Australia 106762Stroke Foundation EMCRSeed2312
6 · The paper itself

Abstract

backgroundMaintaining mobility in the long term after stroke can be challenging. Furthermore, access to ongoing physiotherapy or exercise programs is limited. There is a need to investigate new models of service delivery to improve mobility in the longer term after stroke. A mobility booster program may be a solution, facilitating short-term access to physiotherapy on an as-needed basis. The aim of this project is to determine the feasibility of conducting a clinical trial of a short-term, high-dose mobility booster program (HiWalk) and measure clinical outcomes in order to estimate the power for a future efficacy trial.

methodA multi-site, assessor-blinded pilot randomized trial will be undertaken to compare HiWalk in addition to usual care with usual care alone in 50 participants. Feasibility outcomes include recruitment, adherence, and safety. Clinical outcomes include walking speed, capacity and self-efficacy at 1-month and 6-months. DISCUSSION: A mobility booster program may be a successful way to deliver mobility training in the longer term after stroke. This pilot trial will progress the investigation of this model and assist in planning a future definitive trial. Most importantly, it will confirm the feasibility of delivering a novel high-dose, short-term booster program.

trial registrationANZCTR (ACTRN: ACTRN12623000316606p).

Indexed as

High-doseMobilityPhysiotherapyRehabilitationStroke

Identifiers

PMID40097961
PMCPMC11912660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.